Literature DB >> 19553661

Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.

Maria A Argiriadi1, Tao Xiang, Chengbin Wu, Tariq Ghayur, David W Borhani.   

Abstract

The unique cytokine interleukin-18 (IL-18) acts synergistically with IL-12 to regulate T-helper 1 and 2 lymphocytes and, as such, seems to underlie the pathogenesis of various autoimmune and allergic diseases. Several anti-IL-18 agents are in clinical development, including the recombinant human antibody ABT-325, which is entering trials for autoimmune diseases. Given competing cytokine/receptor and cytokine/receptor decoy interactions, understanding the structural basis for recognition is critical for effective development of anti-cytokine therapies. Here we report three crystal structures: the murine antibody 125-2H Fab fragment bound to human IL-18, at 1.5 A resolution; the 125-2H Fab (2.3 A); and the ABT-325 Fab (1.5 A). These structures, along with human/mouse IL-18 chimera binding data, allow us to make three key observations relevant to the biology and antigenic recognition of IL-18 and related cytokines. First, several IL-18 residues shift dramatically (> 10 A) upon binding 125-2H, compared with unbound IL-18 (Kato, Z., Jee, J., Shikano, H., Mishima, M., Ohki, I., Ohnishi, H., Li, A., Hashimoto, K., Matsukuma, E., Omoya, K., Yamamoto, Y., Yoneda, T., Hara, T., Kondo, N., and Shirakawa, M. (2003) Nat. Struct. Biol. 10, 966-971). IL-18 thus exhibits plasticity that may be common to its interactions with other receptors. Related cytokines may exhibit similar plasticity. Second, ABT-325 and 125-2H differ significantly in combining site character and architecture, thus explaining their ability to bind IL-18 simultaneously at distinct epitopes. These data allow us to define the likely ABT-325 epitope and thereby explain the distinct neutralizing mechanisms of both antibodies. Third, given the high 125-2H potency, 10 well ordered water molecules are trapped upon complex formation in a cavity between two IL-18 loops and all six 125-2H complementarity-determining regions. Thus, counterintuitively, tight and specific antibody binding may in some cases be water-mediated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553661      PMCID: PMC2782040          DOI: 10.1074/jbc.M109.023887

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  IL-18 in patients with multiple sclerosis.

Authors:  J Losy; A Niezgoda
Journal:  Acta Neurol Scand       Date:  2001-09       Impact factor: 3.209

2.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

Authors:  S H Kim; M Eisenstein; L Reznikov; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 4.  Interleukin-18 regulates both Th1 and Th2 responses.

Authors:  K Nakanishi; T Yoshimoto; H Tsutsui; H Okamura
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Authors:  B Siegmund; G Fantuzzi; F Rieder; F Gamboni-Robertson; H A Lehr; G Hartmann; C A Dinarello; S Endres; A Eigler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

6.  Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

Authors:  C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

8.  Structural features of the interaction between an anti-clonotypic antibody and its cognate T-cell antigen receptor.

Authors:  G Mazza; D Housset; C Piras; C Grégoire; J C Fontecilla-Camps; B Malissen
Journal:  J Mol Biol       Date:  1999-04-09       Impact factor: 5.469

9.  Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.

Authors:  M Yamamura; M Kawashima; M Taniai; H Yamauchi; T Tanimoto; M Kurimoto; Y Morita; Y Ohmoto; H Makino
Journal:  Arthritis Rheum       Date:  2001-02

10.  von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule.

Authors:  R Celikel; Z M Ruggeri; K I Varughese
Journal:  Nat Struct Biol       Date:  2000-10
View more
  13 in total

1.  Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule.

Authors:  Clarissa G Jakob; Rohinton Edalji; Russell A Judge; Enrico DiGiammarino; Yingchun Li; Jijie Gu; Tariq Ghayur
Journal:  MAbs       Date:  2013-04-02       Impact factor: 5.857

Review 2.  Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.

Authors:  Brian Krumm; Yan Xiang; Junpeng Deng
Journal:  Protein Sci       Date:  2014-03-04       Impact factor: 6.725

3.  Crystallization of interleukin-18 for structure-based inhibitor design.

Authors:  Brian Krumm; Xiangzhi Meng; Yan Xiang; Junpeng Deng
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-20       Impact factor: 1.056

4.  Structural insights into the assembly and activation of IL-1β with its receptors.

Authors:  Dongli Wang; Senyan Zhang; Liang Li; Xi Liu; Kunrong Mei; Xinquan Wang
Journal:  Nat Immunol       Date:  2010-08-29       Impact factor: 25.606

Review 5.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

6.  Anti-digoxin Fab variants generated by phage display.

Authors:  Viviane Midori Murata; Mariana Costa Braga Schmidt; Jorge Kalil; Lilian Rumi Tsuruta; Ana Maria Moro
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

7.  Biophysical characterization and structure of the Fab fragment from the NIST reference antibody, RM 8671.

Authors:  Ioannis Karageorgos; Elyssia S Gallagher; Connor Galvin; D Travis Gallagher; Jeffrey W Hudgens
Journal:  Biologicals       Date:  2017-09-29       Impact factor: 1.856

Review 8.  Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE).

Authors:  Claudio Ponticelli; Gabriella Moroni
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20

9.  The structural basis for receptor recognition of human interleukin-18.

Authors:  Naotaka Tsutsumi; Takeshi Kimura; Kyohei Arita; Mariko Ariyoshi; Hidenori Ohnishi; Takahiro Yamamoto; Xiaobing Zuo; Katsumi Maenaka; Enoch Y Park; Naomi Kondo; Masahiro Shirakawa; Hidehito Tochio; Zenichiro Kato
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

10.  The study of degradation mechanisms of glyco-engineered plant produced anti-rabies monoclonal antibodies E559 and 62-71-3.

Authors:  Sindisiwe G Buthelezi; Heini W Dirr; Ereck Chakauya; Rachel Chikwamba; Lennart Martens; Tsepo L Tsekoa; Elien Vandermarliere; Stoyan H Stoychev
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.